1. Home
  2. DERM vs BTMD Comparison

DERM vs BTMD Comparison

Compare DERM & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DERM
  • BTMD
  • Stock Information
  • Founded
  • DERM 2014
  • BTMD 2012
  • Country
  • DERM United States
  • BTMD United States
  • Employees
  • DERM N/A
  • BTMD N/A
  • Industry
  • DERM Biotechnology: Pharmaceutical Preparations
  • BTMD Medicinal Chemicals and Botanical Products
  • Sector
  • DERM Health Care
  • BTMD Health Care
  • Exchange
  • DERM Nasdaq
  • BTMD Nasdaq
  • Market Cap
  • DERM 174.7M
  • BTMD 104.2M
  • IPO Year
  • DERM 2021
  • BTMD N/A
  • Fundamental
  • Price
  • DERM $6.88
  • BTMD $4.00
  • Analyst Decision
  • DERM Strong Buy
  • BTMD Strong Buy
  • Analyst Count
  • DERM 2
  • BTMD 1
  • Target Price
  • DERM $10.00
  • BTMD $8.00
  • AVG Volume (30 Days)
  • DERM 80.1K
  • BTMD 185.1K
  • Earning Date
  • DERM 05-20-2025
  • BTMD 05-07-2025
  • Dividend Yield
  • DERM N/A
  • BTMD N/A
  • EPS Growth
  • DERM N/A
  • BTMD 123.33
  • EPS
  • DERM N/A
  • BTMD 0.60
  • Revenue
  • DERM $56,134,000.00
  • BTMD $199,379,000.00
  • Revenue This Year
  • DERM $29.83
  • BTMD $6.20
  • Revenue Next Year
  • DERM $54.88
  • BTMD $9.24
  • P/E Ratio
  • DERM N/A
  • BTMD $6.67
  • Revenue Growth
  • DERM N/A
  • BTMD 6.44
  • 52 Week Low
  • DERM $3.20
  • BTMD $3.04
  • 52 Week High
  • DERM $7.84
  • BTMD $8.44
  • Technical
  • Relative Strength Index (RSI)
  • DERM 52.73
  • BTMD 61.89
  • Support Level
  • DERM $6.47
  • BTMD $3.15
  • Resistance Level
  • DERM $7.15
  • BTMD $3.52
  • Average True Range (ATR)
  • DERM 0.49
  • BTMD 0.22
  • MACD
  • DERM -0.09
  • BTMD 0.07
  • Stochastic Oscillator
  • DERM 37.25
  • BTMD 85.37

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.

Share on Social Networks: